People › Sara R. Simon

Sara R. Simon

Counsel

New York, NY | Morristown, NJ
(973) 889-4080
SRSimon@pbnlaw.com
Overview Experience Recognitions Memberships Community Involvement News Articles Events Speaking Engagements Media Mentions
LinkedIn Profile
vCard
Print
Share with:

Overview

Sara R. Simon is counsel to Porzio, Bromberg & Newman, P.C. and a member of the firm's Life Sciences Compliance and Regulatory Counseling Department. 

Sara counsels pharmaceutical, medical device and biotechnology companies on a variety of compliance-related issues, including federal and state fraud and abuse laws, FDA promotional regulations, state drug price transparency and aggregate spend, and industry standards regarding interactions with healthcare professionals. 

Sara provides regulatory healthcare compliance advice regarding federal and state anti-kickback and anti-referral laws and is fluent in organizational HIPAA policies and procedures. She also has structured varied business arrangements between health care providers, focusing on structuring healthcare practices, and counseling clients regarding compliance with state and federal health care laws and regulatory issues.

To further advance her knowledge in the life sciences industry, Sara has also completed the Seton Hall Law US Healthcare Compliance Certification Program, where she also served as Director. 

Recognition

No aspect of this or any advertisement has been approved by the Supreme Court of New Jersey. For ranking methodologies, please see here. 

  • Best Lawyers: Ones to Watch® in America - Health Care Law (2023-2025)

News

No aspect of this or any advertisement has been approved by the Supreme Court of New Jersey. For ranking methodologies, please see here. 

Articles

Events

Speaking Engagements

  • "Hot Topics in State Law Compliance," 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, 10/29/2024
  • "State and Drug Price Transparency Reporting Strategy and Management," Informa Pricing & Contracting USA 2024, 5/21/2024
  • "Organizational Management Issues, Reputational Risks, and Creating a Purposeful Corporate Culture," Porzio's Seventh Annual Ethics & Eggs CLE Seminar, 12/07/2023
  • "Compliance, Ethics & Privilege," 5th Annual Women in Business & Law, 11/13/2023
  • "Assessing Compliance Priorities: Considerations for Conducting an Effective and Collaborative Compliance Risk Assessment," 24th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, 10/25/2023
  • "State Drug Price Transparency: What's New and On The Horizon," Presenter, Porzio Life Sciences, Life Sciences Palooza, Atlantic City, NJ, 9/26/2023
  • "Recent Regulatory Updates and Developments," 7th Annual Pharma Pricing, Reimbursement and Market Access Conference, 5/25/2023
  • "Ask the Experts - What Keeps You Up at Night? 2024 and Beyond," Drug Pricing Transparency Conference, 5/16/2023
  • "Understanding Prescription Drug Affordability Boards," Drug Pricing Transparency Conference, 5/16/2023
  • "State of the Industry – A Closer Look at the Drug Pricing Transparency Landscape," Drug Pricing Transparency Congress, Philadelphia, PA, 3/29/2022
  • "Anticipating Reporting Responsibilities and Making Sure Your Company is Prepared," Porzio Life Sciences Webinar, 9/15/2021
  • International Pharma Congress Mini Summit 21: Global Price Transparent Reporting  , 6/15/2021
  • Porzio Life Sciences Webinar - 2021 Life Sciences Compliance Outlook, 3/16/2021
  • "2021 Life Sciences Compliance Outlook," Porzio Life Sciences, Webinar, 3/16/2021
  • "State of the Industry – Drug Pricing Transparency Landscape," 3rd Annual Pharma Pricing, Reimbursement & Market Access, 12/02/2020
  • "State of the Industry – Drug Pricing Transparency Landscape Address," 6th Edition Drug Pricing Transparency, 11/16/2020
  • "State of the Industry – Drug Pricing Transparency Landscape Address," 6th Edition Drug Pricing Transparency, 11/16/2020